Yahoo
NasdaqGS - Delayed Quote USD

Materialise NV (MTLS)

7.46 +0.43 (+6.12%)
At close: September 4 at 4:00:01 PM EDT
7.46 0.00 (0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade MTLS on Coinbase
Chart Range Bar
Loading chart for MTLS
  • Previous Close 7.03
  • Open 7.02
  • Bid 7.52 x 100
  • Ask 9.08 x 200
  • Day's Range 7.00 - 7.59
  • 52 Week Range 4.78 - 7.60
  • Volume 258,157
  • Avg. Volume 102,747
  • Market Cap (intraday) 431.642M
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) 26.64
  • EPS (TTM) 0.28
  • Earnings Date (est.) Oct 28, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.94

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

www.materialise.com

2,556

Full Time Employees

December 31

Fiscal Year Ends

Technology

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .

YTD Return

MTLS
35.39%
BEL 20 (^BFX)
15.26%

1-Year Return

MTLS
51.32%
BEL 20 (^BFX)
23.33%

3-Year Return

MTLS
12.86%
BEL 20 (^BFX)
60.05%

5-Year Return

MTLS
69.20%
BEL 20 (^BFX)
35.98%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 66.28M
Earnings 1.82M
Profit Margin 2.75%

Q3

FY25

Q4

FY25

Q1

FY26

0
20M
40M
60M
4.0%
6.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

8.08
8.94 Average
7.46 Current
9.98 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 4/24/2024
Analyst Cantor Fitzgerald
Rating Action Initiated
Rating Overweight
Price Action Announces
Price Target 9.5

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.84%

  • Return on Assets (ttm)

    1.65%

  • Return on Equity (ttm)

    5.22%

  • Revenue (ttm)

    272.77M

  • Net Income Avi to Common (ttm)

    13.21M

  • Diluted EPS (ttm)

    0.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    133.74M

  • Total Debt/Equity (mrq)

    23.23%

  • Levered Free Cash Flow (ttm)

    13.11M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: